UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062529
Receipt number R000071575
Scientific Title Changes in Anorectal Function and Defecatory Dysfunction Before and After Temporary Stoma Closure Following Rectal Cancer Surgery After Neoadjuvant Chemoradiotherapy: A Prospective Interventional Study
Date of disclosure of the study information 2026/08/10
Last modified on 2026/08/09 18:31:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Changes in Anorectal Function and Defecatory Dysfunction Before and After Temporary Stoma Closure Following Rectal Cancer Surgery After Neoadjuvant Chemoradiotherapy

Acronym

NeoAF Study

Scientific Title

Changes in Anorectal Function and Defecatory Dysfunction Before and After Temporary Stoma Closure Following Rectal Cancer Surgery After Neoadjuvant Chemoradiotherapy: A Prospective Interventional Study

Scientific Title:Acronym

NeoAF Study

Region

Japan


Condition

Condition

Rectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to prospectively evaluate changes in anorectal function and defecatory dysfunction before and after temporary stoma closure in patients who have undergone rectal cancer surgery with temporary stoma creation following neoadjuvant therapy. Changes in objective anorectal function, bowel function, and quality of life before and after stoma closure will be assessed using anorectal manometry, defecography, and patient-reported questionnaires.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Incidence of major low anterior resection syndrome (LARS) at 6 months after stoma closure

Key secondary outcomes

Changes in the incidence and severity of low anterior resection syndrome (LARS), anorectal function, and quality of life (QOL) before and after temporary stoma closure


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Anorectal manometry, defecography, and questionnaire assessments will be performed before and after temporary stoma closure.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who meet all of the following eligibility criteria will be considered eligible:

1. Patients who have undergone sphincter-preserving rectal resection with temporary ileostomy for rectal cancer following neoadjuvant therapy.
2. Patients scheduled for temporary stoma closure within 3 months to 1 year after rectal resection.
3. Patients confirmed by colonoscopy to have no abnormal findings, such as anastomotic stricture or ulceration.
4. Patients aged 20 years or older at the time of informed consent.
5. Patients who have provided written informed consent voluntarily after receiving an explanation of the study using the written informed consent document.

Key exclusion criteria

Patients meeting any of the following criteria will be excluded:

1. Patients who are unable to complete the questionnaires or undergo anorectal function testing due to dementia, psychiatric disorders, or other conditions.
2. Patients who do not wish to undergo temporary stoma closure.
3. Patients with an allergy to barium or wheat flour.
4. Patients whom the principal investigator considers unsuitable for participation in the study for safety reasons.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Osamu
Middle name
Last name Itano

Organization

International University of Health and Welfare Narita Hospital

Division name

Department of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery

Zip code

286-8520

Address

852 Hatakeda, Narita, Chiba

TEL

0476-35-5600

Email

itano@iuhw.ac.jp


Public contact

Name of contact person

1st name Ami
Middle name
Last name Nishijima

Organization

International University of Health and Welfare Narita Hospital

Division name

Department of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery

Zip code

286-8520

Address

852 Hatakeda, Narita, Chiba

TEL

0476-35-5600

Homepage URL


Email

anishijima@ihwg.jp


Sponsor or person

Institute

International University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

International University of Health and Welfare

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional review board, International University of Health and Welfare

Address

852 Hatakeda, Narita, Chiba

Tel

0476-35-5600

Email

rinri_md@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2026 Year 07 Month 22 Day

Date of IRB

2026 Year 07 Month 22 Day

Anticipated trial start date

2026 Year 07 Month 23 Day

Last follow-up date

2027 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 08 Month 09 Day

Last modified on

2026 Year 08 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071575